The Mechanism of Action of a New Class of Nucleoside Analogs Targeting Gastrointestinal Tumours
Gastrointestinal malignancies such as liver and pancreatic cancers are the deadliest due to late detection and drug resistance. Nucleoside analogues, like Gemcitabine, are the conventional therapy despite their little impact on survival and off-target toxicity. A novel class of nucleoside analogues...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2019
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/38845 http://dx.doi.org/10.20381/ruor-23097 |